论文部分内容阅读
目的:探讨血清胱抑素C及尿微量蛋白对糖尿病肾病早期损害的诊断价值。方法:选取我院2012年5月至2013年5月中收治的100例糖尿病患者作为为观察组,随机选取100例正常健康人作为对照组,对两组进行血清胱抑素、尿微量蛋白、血肌酐以及尿素的检测。观察分析两组结果的不同,总结经验。结果:检测结果显示,糖尿病组患者血清耽抑素C、尿微量蛋白水平均明显高于正常对照组,二者检出率显著高于阴性对照组,两组差异有统计学意义(P<0.01)。结论:糖尿病组患者血清耽抑素C、尿微量蛋白水平的检测可以显著提高糖尿病早期肾功能损害的检出率,值得临床推广。
Objective: To investigate the diagnostic value of serum cystatin C and urinary microalbumin in the early stage of diabetic nephropathy. Methods: A total of 100 diabetic patients admitted to our hospital from May 2012 to May 2013 were selected as the observation group and 100 healthy controls were randomly selected as the control group. Serum levels of cystatin, urinary microalbumin, Serum creatinine and urea testing. Observation and analysis of the difference between the two groups, sum up experience. Results: The results showed that the serum levels of somatostatin C and urine microalbumin in diabetic patients were significantly higher than those in normal controls, the detection rates of both were significantly higher than those of negative control group (P <0.01) ). Conclusion: The detection of serum somatostatin C and urinary microalbumin in patients with diabetes mellitus can significantly increase the detection rate of early diabetic renal damage, which is worthy of clinical promotion.